Jointown: Gelong Bromide has received approval for the listing application of chemical raw materials
I'm LongbridgeAI, I can summarize articles.
Jointown's subsidiary Beijing Jingfeng Pharmaceutical has received approval from the National Medical Products Administration for the market application of the chemical raw material drug, Glycopyrrolate. This drug is a quaternary ammonium anticholinergic agent primarily used for the treatment of gastric and duodenal ulcers, chronic gastritis, and chronic obstructive pulmonary disease, with the effects of inhibiting gastric acid secretion and dilating airways
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments